Showing 1,241 - 1,260 results of 4,736 for search '"Patient"', query time: 0.09s Refine Results
  1. 1241

    Evaluation of postoperative pain on Transversus Abdominis Plane block and Erector Spinae Plane block in patients undergoing gynecological surgery: a prospective, comparative study by D. Tavianto, O. M. Pison, Azka Putra Rakhmatullah

    Published 2024-11-01
    “…OBJECTIVES: This study aims to compare postoperative pain in patients undergoing either ESP blocks or TAP blocks, and the need for postoperative morphine in patients undergoing gynecological surgery.MATERIALS AND METHODS: This was a single-center, prospective, double-arm, comparative study. …”
    Get full text
    Article
  2. 1242
  3. 1243
  4. 1244

    The prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in colorectal cancer and colorectal anastomotic leakage patients: a retrospective study by Nuo Xu, Jian-Xin Zhang, Jia-Jie Zhang, Zhuo Huang, Lian-Chun Mao, Zhi-Yong Zhang, Wei-Dong Jin

    Published 2025-02-01
    “…Results A total of 890 patients with colorectal cancer, 102 patients with CAL, and 788 patients with non- anastomotic leakage (AL) colorectal cancer were enrolled for a median follow-up of 96 months (quartile range 33–133). …”
    Get full text
    Article
  5. 1245
  6. 1246
  7. 1247
  8. 1248

    Comparative Effectiveness of Remestemcel-L-rknd versus Ruxolitinib in Pediatric Patients with Steroid-Refractory Acute Graft-Versus-Host Disease using Simulated Treatment Comparisons by Gabriel Tremblay, Dimitrios Tomaras, Eric Strati, Anna Forsythe

    Published 2021-02-01
    “…**Methods:** Regression techniques were used to adjust individual patient-level data from the remestemcel-L-rknd trial to mutually reported baseline characteristics from the ruxolitinib trial. …”
    Get full text
    Article
  9. 1249
  10. 1250

    Efficacy and safety of the Russian protease inhibitor narlaprevir at treatment-naive and earlier treated noncirrhotic patients with the 1st genotype chronic hepatitis C (PIONEER study) by M. V. Mayevskaya, V. T. Ivashkin, O. O. Znoyko, Ye. A. Klimova, D. T. Abdurakhmanov, I. G. Bakulin, P. O. Bogomolov, E. Z. Burnevich, M. Yu. Galushko, N. I. Geyvandova, K. V. Zhdanov, Ye. V. Esaulenko, S. N. Kizhlo, D. Yu. Konstantinov, N. I. Mironova, V. G. Morozov, Ye. A. Strebkova, I. G. Nikitin, M. F. Osipenko, V. D. Pasechnikov, O. I. Sagalova, I. M. Khayertynova, V. P. Chulanov, A. A. Yakovlev, I. A. Vasyutin, Ye. P. Tarkhova, E. N. Krasavina, M. Yu. Samsonov

    Published 2018-08-01
    “…The sustained virologic response in 24 weeks after treatment termination (SVR24) in the main group (NVR/RTV, PEG IFN/RBV)) was achieved in 89.1% (163/183) of treatment-naïve and 69.7% (69/99) of earlier treated patients. SVR24 was achieved in 86.5% (32/37) of patients with relapse after previous peg-IFN/ RBV treatment course. …”
    Get full text
    Article
  11. 1251
  12. 1252

    Impact of adjuvant trastuzumab therapy and its discontinuation on cardiac function and mortality in patients with early-stage breast cancer: An analysis based on the Japanese Receipt Claim Database by Keiko Miyazato, Hiroshi Ohtsu, Akihiko Shimomura, Naohiro Yonemoto, Chikako Shimizu, Kazuhiro Sase, Shinichiro Ueda

    Published 2025-02-01
    “…Our findings suggest that discontinuation of trastuzumab treatment worsens patient prognosis due to insufficient treatment of breast cancer rather than due to the cardiovascular toxicity of the drug.…”
    Get full text
    Article
  13. 1253

    Clinical Characteristic of Patients Underwent Bone Mineral Density Examination in Prof.... by R. Andhi Prijosedjati, Pamudji Utomo, Leli Sabariyah, Ahmad Fauzi

    Published 2024-04-01
    “…This study investigates the characteristics of patients who had BMD examinations at the Prof. Dr. …”
    Get full text
    Article
  14. 1254

    Polypragmasy at treatment of <i>H. pylori</i> infection in patients with concomitant diseases of other organs and systems.... by S. G. Burkov, N. V. Shornikova

    Published 2011-05-01
    “…Issues of drug interaction, side effects development at patients with combined diseases, requiring eradication treatment, are taken into account.Original positions. …”
    Get full text
    Article
  15. 1255
  16. 1256

    Risk factors for difficult peripheral venous cannulation in hospitalised patients. Protocol for a multicentre case–control study in 48 units of eight public hospitals in Spain by Jose Miguel Morales-Asencio, Ian Blanco-Mavillard, Miguel Angel Rodríguez-Calero, Ismael Fernandez-Fernandez, Luis Javier Molero-Ballester, Catalina Matamalas-Massanet, Luis Moreno-Mejias, Joan Ernest de Pedro-Gomez

    Published 2018-02-01
    “…Introduction Patients with difficult venous access experience undesirable effects during healthcare, such as delayed diagnosis and initiation of treatment, stress and pain related to the technique and reduced satisfaction. …”
    Get full text
    Article
  17. 1257

    Clinical treatment score Post-5 Years (CTS5) predicts the benefit of postmastectomy radiotherapy in patients with T1-2N1 luminal breast cancer by Ke Liu, Guan-Qiao Li, Si-Qi Li, Xue-Qin Chen, San-Gang Wu

    Published 2025-02-01
    “…Purpose: To investigate the clinical value of Clinical Treatment Score Post-5 Years (CTS5) to predict the survival benefits of postmastectomy radiotherapy (PMRT) of patients with T1-2N1 luminal breast cancer (BC). Methods: Patients who were diagnosed with T1-2N1 luminal BC between 2010 and 2015 were included in the Surveillance, Epidemiology, and End Results database. …”
    Get full text
    Article
  18. 1258

    Research of <i>PNPLA3</i> I148M Gene Polymorphism in Patients with Non-Alcoholic Fatty Liver Disease, with Liver Cirrhosis and with Hepatocellular Carcinoma by V. V. Petkau, G. A. Tsaur, E. N. Bessonova, A. A. Karimova

    Published 2023-11-01
    “…NAFLD patients with PNPLA3 I148M polymorphism have a significantly higher chance of developing LC and HCC. …”
    Get full text
    Article
  19. 1259

    Internal Dosimetry in Patients Undergoing Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-[DOTA0-Tyr3] Octerotate: A Single-Center Experience by Elahe Mahmoudi, Mahasti Amoui, Mohammad Reza Deevband, Elahe Pirayesh, Mohammad Reza Asgari, Mehdi Ghorbani

    Published 2025-01-01
    “…Materials and Methods: Whole body planar scintigraphy images were collected for 10 patients, which are used as the basis for the personalized patient dosimetry calculations. …”
    Get full text
    Article
  20. 1260

    Association between red blood cell distribution width-to-albumin ratio at admission and all-cause mortality in patients with acute pancreatitis based on the MIMIC-III database. by Qingsong Wu, Lianyi Liao, Qingjun Deng

    Published 2025-01-01
    “…<h4>Objective</h4>The association between red blood cell distribution width-to-albumin (RDW/ALB) ratio (RAR) and all-cause mortality in patients with acute pancreatitis has not been fully delineated. …”
    Get full text
    Article